{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:23:07Z","timestamp":1782814987172,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ygyno.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T16:35:25Z","timestamp":1490286925000},"page":"269-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Utility of radiation therapy for early-stage uterine papillary serous carcinoma"],"prefix":"10.1016","volume":"145","author":[{"given":"Stephanie","family":"Cham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Tergas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Y.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cande V.","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred I.","family":"Neugut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.03.003_bb0005","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/PAS.0b013e31802ee494","article-title":"Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences","volume":"31","author":"Soslow","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2017.03.003_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/gyno.2000.5737","article-title":"The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma","volume":"77","author":"Cirisano","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/gyno.1994.1207","article-title":"Uterine papillary serous carcinoma revisited","volume":"54","author":"Hendrickson","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0030","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.24247","article-title":"Platinum\/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma","volume":"115","author":"Fader","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2017.03.003_bb0035","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2008.11.016","article-title":"Stage II uterine papillary serous carcinoma: carboplatin\/paclitaxel chemotherapy improves recurrence and survival outcomes","volume":"112","author":"Fader","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0040","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.6004\/jnccn.2015.0162","article-title":"Uterine sarcoma, version 1.2016: featured updates to the NCCN guidelines","volume":"13","author":"Koh","year":"2015","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0045","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2017.03.003_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1525-1438.2006.00319.x","article-title":"Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals","volume":"16","author":"Paulsen","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2017.03.003_bb0055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0021-9681(86)90111-6","article-title":"Assessing illness severity: does clinical judgment work?","volume":"39","author":"Charlson","year":"1986","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2016.02.002","article-title":"Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)","volume":"141","author":"Bernardini","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0070","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2003.08.027","article-title":"Uterine papillary serous carcinoma: comparisons of outcomes in surgical Stage I patients with and without adjuvant therapy","volume":"91","author":"Huh","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0075","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ygyno.2007.01.041","article-title":"Outcomes in surgical stage I uterine papillary serous carcinoma","volume":"105","author":"Havrilesky","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0080","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1525-1438.2007.01082.x","article-title":"Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?","volume":"18","author":"Kwon","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2017.03.003_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ygyno.2015.01.544","article-title":"Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study","volume":"137","author":"Mahdi","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2013.01.025","article-title":"A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium","volume":"129","author":"Jhingran","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2007.09.025","article-title":"Pilot phase II trial of radiation \u201csandwiched\u201d between combination paclitaxel\/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC)","volume":"108","author":"Fields","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0105","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2016.27.e19","article-title":"The impact of combined radiation and chemotherapy on outcome in uterine papillary serous carcinoma compared to chemotherapy alone","volume":"27","author":"Mahdi","year":"2016","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ygyno.2017.03.003_bb0115","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/IGC.0000000000000464","article-title":"Trends in treatment of uterine serous cancer in the Medicare population","volume":"25","author":"Rauh-Hain","year":"2015","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2017.03.003_bb0120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2017.03.003_bb0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ygyno.2012.07.112","article-title":"Five-year outcomes of adjuvant carboplatin\/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer","volume":"127","author":"Kiess","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0130","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ygyno.2013.09.019","article-title":"Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy","volume":"131","author":"Desai","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5114\/jcb.2015.48539","article-title":"High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma","volume":"7","author":"Damast","year":"2015","journal-title":"J. Contemp. Brachytherapy"},{"key":"10.1016\/j.ygyno.2017.03.003_bb0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.06.012","article-title":"Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy","volume":"98","author":"Kelly","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.03.003_bb0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(97)00581-6","article-title":"Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy","volume":"40","author":"Turner","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817302044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817302044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T03:36:59Z","timestamp":1568950619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817302044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0090825817302044"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of radiation therapy for early-stage uterine papillary serous carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}